Specific Drug Use Survey for EFIENT Tablets Prasugrel For Japanese patients with ACS in short-term clinical practice.

Specific Drug Use Survey for EFIENT Tablets Prasugrel For Japanese patients with ACS in short-term clinical practice. - PRASFIT-Practice I

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014699

Enrollment

500

Registered

2014-07-30

Start date

2014-05-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACS patients who are to undergo PCI or who have just undergone PCI

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ACS patients who are to undergo PCI or who have just undergone PCI.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Safety 1) Frequency of adverse drug reactions 2) Frequency of Severe adverse events 3) Frequency of bleeding events Efficacy - Frequency of cardiovascular events Special population - Safety and efficacy in patients with hepatic disease, renal disease, and elderly	—

Countries

Japan

Contacts

Public ContactShuichi Chikada

Daiichi Sankyo Co., Ltd. Pharmacovigilance Department

chikada.shuichi.ic@daiichisankyo.co.jp+81-3-6225-1044

Outcome results